These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

504 related items for PubMed ID: 14161953

  • 1. [CLINICAL EXPERIENCES WITH A NEW ORAL HYPOGLYCEMIC DRUG, ACETOHEXAMIDE].
    CHANIS RA.
    Arch Med Panamenos; 1963 Dec; 12():193-206. PubMed ID: 14161953
    [No Abstract] [Full Text] [Related]

  • 2. ACETOHEXAMIDE ('DIMELOR') IN DIABETES.
    HERMAN M, JACKSON WP.
    S Afr Med J; 1964 Jul 18; 38():519-22. PubMed ID: 14182168
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. ACETOHEXAMIDE: CLINICAL EVALUATION OF A NEW ORAL ANTIDIABETIC AGENT.
    ALTERMAN SL, LIEBER AL.
    Curr Ther Res Clin Exp; 1964 Mar 18; 6():148-55. PubMed ID: 14131413
    [No Abstract] [Full Text] [Related]

  • 5. [CLINICAL OBSERVATIONS DONE WITH ACETOHEXAMIDE IN THE ORAL TREATMENT OF DIABETES MELLITUS IN THE ADULT].
    PAES E, SILVAGOMES FJ, CANAS MA.
    Rev Iber Endocrinol; 1964 Mar 18; 11():5-17. PubMed ID: 14134258
    [No Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. ACETOHEXAMIDE--A NEW ORAL AGENT FOR CONTROL OF DIABETES MELLITUS. A PRELIMINARY REPORT.
    FENTRESS V, COOKSEY NJ.
    Harper Hosp Bull; 1964 Mar 18; 22():111-4. PubMed ID: 14159417
    [No Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. THE ORAL HYPOGLYCEMIC COMPOUNDS.
    FERGUSON BD.
    Med Clin North Am; 1965 Jul 18; 49():929-38. PubMed ID: 14300336
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. USE OF ACETOHEXAMIDE (DYMELOR) IN DIABETIC PATIENTS WITH SECONDARY FAILURES TO ANTIDIABETIC DRUGS.
    GOODMAN JI.
    J Indiana State Med Assoc; 1964 Oct 18; 57():1133-8. PubMed ID: 14199301
    [No Abstract] [Full Text] [Related]

  • 16. CLINICAL EFFECTS OF A NEW, POTENT, NON-TOXIC SULFONYLUREA (TOLAZAMIDE).
    GRINNELL EH, SKILLMAN TG, BARSE R, MOLLER CL.
    Curr Ther Res Clin Exp; 1964 Jul 18; 6():433-41. PubMed ID: 14203273
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. ACETOHEXAMIDE AND TOLBUTAMIDE EFFECTS IN NON-DIABETIC AND DIABETIC ADULTS.
    DANOWSKI TS, SARVER ME, BONESSI JV, MOSES C.
    Proc Soc Exp Biol Med; 1964 Mar 18; 115():578-80. PubMed ID: 14155769
    [No Abstract] [Full Text] [Related]

  • 19. Acetohexamide: comparison with other sulfonylurea compounds in the treatment of diabetes mellitus.
    BOSHELL BR, WILENSKY AS, BARRETT JC, ALMON JV.
    Clin Pharmacol Ther; 1962 Mar 18; 3():750-7. PubMed ID: 14014164
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.